Gastroduodenitis Associated with Active Ulcerative Colitis Treated with Infliximab~Different Clinical Course in the Colon and Gastroduodenal Lesions~-Reference-Cited by-同舟云学术

Gastroduodenitis Associated with Active Ulcerative Colitis Treated with Infliximab~Different Clinical Course in the Colon and Gastroduodenal Lesions~

Published:2023 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hayashi Tomoyuki¹,Terashima Takeshi¹,Nishitani Masaki¹,Orita Noriaki¹,Miyazawa Masaki¹,Seki Akihiro¹,Nakagawa Hidetoshi¹,Nio Kouki¹,Iida Noriho¹,Yamada Shinya²,Takatori Hajime²,Shimakami Tetsuro¹,Yamashita Taro¹

Affiliation:

1. Department of Gastroenterology, Kanazawa University Hospital, Japan

2. Endoscopy center, Kanazawa University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_2047-23/_pdf

Reference16 articles.

1. 1. Travis SP, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 61: 535-542, 2012.

2. 2. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317: 1625-1629, 1987.

3. 3. Valdez R, Appelman HD, Bronner MP, et al. Diffuse duodenitis associated with ulcerative colitis. Am J Surg Pathol 24: 1407-1413, 2000.

4. 4. Ikeuchi H, Hori K, Nishigami T, et al. Diffuse gastroduodenitis and pouchitis associated with ulcerative colitis. World J Gastroenterol 12: 5913-5915, 2006.

5. 5. Terashima S, Hoshino Y, Kanzaki N, et al. Ulcerative duodenitis accompanying ulcerative colitis. J Clin Gastroenterol 32: 172-175, 2001.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent occurrence of ulcerative duodenitis and ulcerative colitis displaying unique responses to golimumab and ustekinumab;Clinical Journal of Gastroenterology;2024-07-18